Qu’apportent les recommandations 2012 de l’European Society of Clinical Microbiology and Infectious Diseases sur la prise en charge des candidoses invasives chez les patients non neutropéniques ?
Author:
- 23 January 2014
- journal article
- Published by Lavoisier in Réanimation
- Vol. 23 (3) , 243-244
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory ConcentrationsClinical Infectious Diseases, 2013
- EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trialTrials, 2013
- ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patientsClinical Microbiology and Infection, 2012
- Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source ControlClinical Infectious Diseases, 2012
- Systemic antifungal therapy in critically ill patients without invasive fungal infection*Critical Care Medicine, 2012
- Antifungal use influences Candida species distribution and susceptibility in the intensive care unitJournal of Antimicrobial Chemotherapy, 2011
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 PatientsAntimicrobial Agents and Chemotherapy, 2011
- Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter studyCritical Care Medicine, 2009
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009